Last Price$80.48Cboe Real-Time Last Sale as of 3:42PM ET 2/21/20
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-2.29(2.77%)
Bid (Size)$80.46 (100)
Ask (Size)$80.50 (200)
Day Low / High$80.68 - 82.67
Volume946.6 K
  • Latest Stories
  • Commentary and Analysis
--Analyst Actions: Oppenheimer Raises Incyte's Price Target to $99 From $96, Keeps Outperform Rating
9:21AM ET 2/20/2020 MT Newswires

Price: 82.00, Change: -0.42, Percent Change: -0.51 ...

--Analyst Actions: Nomura Raises Incyte's Price Target to $116 From $111, Reiterates Buy Rating
11:48AM ET 2/19/2020 MT Newswires

Price: 81.61, Change: +2.31, Percent Change: +2.91 ...

Incyte Says Study on Eczema Drug Meets Primary Endpoint
8:36AM ET 2/19/2020 MT Newswires

Drug maker Incyte (INCY) said Wednesday that the third phase of its clinical trial program testing ruxolitinib cream on eczema met its primary endpoint. ...

--Analyst Actions: JP Morgan Lowers Price Target for Incyte to $89 From $91, Maintains Overweight Rating
1:08PM ET 2/14/2020 MT Newswires

Price: 77.77, Change: -0.28, Percent Change: -0.36 ...

--Analyst Actions: Goldman Sachs Lifts Price Target for Buy-Rated Incyte to $109 From $108
1:07PM ET 2/14/2020 MT Newswires

Price: 77.78, Change: -0.28, Percent Change: -0.35 ...

--Analyst Actions: RBC Raises Incyte's Price Target to $83 From $80, Keeps Sector Perform Rating
8:56AM ET 2/14/2020 MT Newswires

Price: 77.95, Change: -0.10, Percent Change: -0.13 ...

Insider Trends: Incyte Insider Gets Shares Award Sells Portion for Taxes Easing, 90-Day Buy Trend
9:48PM ET 2/13/2020 MT Newswires

On Feb 11, 2020, Christiana Stamoulis, EVP & CFO, awarded 4,268 shares in Incyte (INCY) and sold 780 shares concurrently to meet tax obligations. After...

Research Alert: CFRA Maintains Hold Opinion On Shares Of Incyte Corporation
2:25PM ET 2/13/2020 MT Newswires

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...

Incyte Q4 Results Top Expectations
9:18AM ET 2/13/2020 MT Newswires

Incyte (INCY) shares rose 2% in pre-market trading after the biopharmaceutical company reported Q4 adjusted EPS of $0.65, down a penny from the year-ago...

Eli Lilly, Incyte Say Investigational Study of Eczema Drug Met Primary Endpoint
6:46AM ET 2/12/2020 MT Newswires

Eli Lilly (LLY) and joint venture partner Incyte (INCY) said late Tuesday that the third phase of their investigational study has proven baricitinib to be...